Market Cap 1.68B
Revenue (ttm) 285.50M
Net Income (ttm) 27.59M
EPS (ttm) N/A
PE Ratio 50.27
Forward PE 85.08
Profit Margin 9.66%
Debt to Equity Ratio -2.54
Volume 2,975,500
Avg Vol 4,890,168
Day's Range N/A - N/A
Shares Out 306.83M
Stochastic %K 48%
Beta 1.08
Analysts Strong Sell
Price Target $10.38

Company Profile

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pul...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 661 5000
Address:
1 Casper Street, Danbury, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 4:31 PM
Enter: $MNKD Calls Strike Price: $6 Expiry Date: NOV 14 2025 Buy in Price: $0.20 - $0.50 Sell Price: $0.28 Profit : +41% (Turn every $1 into $1.41) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
NatesNotes
NatesNotes Oct. 25 at 3:27 PM
SCAM ALERT - though I have already made one post about it, just a heads up to everyone on the stream that the fraudulent account that is attempting to look like mine (same screen name, but no "s" after "Nate") is now apparently also soliciting people to open and fund trading accounts "in order to follow Nate Pile's trades" (or similar); however, please note that it is a SCAM, and rather than opening an account, you should instead report the fraudulent account to ST (click on the three dots associated with that profile and then click "report"). I have sent a message to ST and one of its founders in hopes they will remove the account before anyone gets hurt, but if you could all report @NateNotes as well, it would likely help accelerate the process. Thanks in advance (and, of course, Go $MNKD! :-) ).
1 · Reply
kevinmik
kevinmik Oct. 25 at 3:17 PM
$MNKD Here are the choices facing Mannkind Board of Directors for the future direction of the company to best unlock value for shareholders. The status quo cannot continue and to meet their fiduciary responsibility Mannkind Board of Directors must start doing what's in the best interest of their sareholders. They cannot continue to allow Mannkind Executives to enrich themselves year after year approving undeserved compenstion packages and focus on shareholder value. 1) Sell Mannkind 2) Merge Mannkind With United Therapeutic 3) Restructure Mannkind Spinning Out A New Company 4) Sell Tyvaso DPI Asset To United Therapeutic To Focus Mannkind Other Assets 5) Sign New Partnership Deals 6) Have United Therapeutic or Another Pharma Company Take Equity Stake In Mannkind 7) Expand Mannkind Innovative Inhaled Drug Delivery Platform To Include Multiple Diseases & Disorders 8) Hold Management & CEO Accountable For Growing Shareholder Value, Stock Price & Market Cap 9) Hire New CEO
1 · Reply
kevinmik
kevinmik Oct. 25 at 1:59 PM
$MNKD Furoscix and Furoscx ReadyFlow Autoinjector still MIA from Mannkind website. This should have been ready to go as soon the acquisition deal closed that happened on October 7, 2025.
1 · Reply
beerm
beerm Oct. 25 at 5:21 AM
$MNKD Looks like BP is using hedge funds to increase the short position. I can smell the fears coming from BP.
1 · Reply
Kool_Aid_Mann
Kool_Aid_Mann Oct. 25 at 3:14 AM
$MNKD While all of the indices are setting record highs, MNKD is down 20% for the year, what's new? Down 66% on 10 years, down 90%+ for all time.
1 · Reply
kevinmik
kevinmik Oct. 25 at 2:50 AM
$MNKD Things kick off next Wednesday October 29th, when United Therapeutic releases their 3Q 2025 earnings report and then Mannkind is presenting Inhale-1 full study including safety extension results the next week on Wednesday November 5th and release 3Q Earnings results with host conference call the following day on Thursday November 6th. Mannkind could also release other catalyst updates over the next 2 week. Will be interesting to see where the stock price is trading 2 weeks from today on November 7th. Will it remain stuck in the $5 range or will it finally break above $6, $7 or higher.
2 · Reply
NatesNotes
NatesNotes Oct. 24 at 11:46 PM
$MNKD Love it! After getting burned so badly last time around, it will interesting to see how how much money they're willing to lose on this go 'round before they finally throw in the towel again – you'd think they would have learned their lesson by now! Either way - more fun and excitement (and profits!) for the rest of to look forward to, eh? ;-) As always, thanks for sharing, SLA! Cheers! #knowwhatyouown #factsmatter
2 · Reply
Golf365
Golf365 Oct. 24 at 11:07 PM
$MNKD In 2 weeks time we gained 7 million more short shares. Now at 25 million short. Mike, please leave and take the BOD with ya.
0 · Reply
MrSpeaker
MrSpeaker Oct. 24 at 11:03 PM
$MNKD The_Owl_ What is your take on 7,000,000 +- shares short Mnkd ? Should we be surprised ?
1 · Reply
Latest News on MNKD
MannKind: Durable Cash Engine, Optional Catalysts Pending

Oct 15, 2025, 12:55 PM EDT - 10 days ago

MannKind: Durable Cash Engine, Optional Catalysts Pending


MannKind to Present at Upcoming Investor Conferences

Aug 27, 2025, 4:05 PM EDT - 2 months ago

MannKind to Present at Upcoming Investor Conferences


MannKind Corporation: A Post-Q2 Assessment

Aug 6, 2025, 4:44 PM EDT - 2 months ago

MannKind Corporation: A Post-Q2 Assessment


Top 3 Health Care Stocks That May Rocket Higher This Quarter

Jun 11, 2025, 7:01 AM EDT - 4 months ago

Top 3 Health Care Stocks That May Rocket Higher This Quarter


MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition

May 27, 2025, 12:02 AM EDT - 5 months ago

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition


MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:34 AM EDT - 6 months ago

MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript


MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 9:09 PM EST - 8 months ago

MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript


MoneyShow's Best Investment Ideas For 2025: Part 8

Feb 3, 2025, 9:20 AM EST - 9 months ago

MoneyShow's Best Investment Ideas For 2025: Part 8

DELL FNV MSTR SKE SKYE AMSC


MannKind Expands Executive Leadership Team

Jan 6, 2025, 4:30 PM EST - 10 months ago

MannKind Expands Executive Leadership Team


MannKind to Present at 2024 UBS Healthcare Conference

Nov 5, 2024, 4:15 PM EST - 1 year ago

MannKind to Present at 2024 UBS Healthcare Conference


More Adults With Type 1 Diabetes Achieved A1C Goal (

Sep 30, 2024, 6:00 AM EDT - 1 year ago

More Adults With Type 1 Diabetes Achieved A1C Goal (


MannKind to Present at Upcoming Conferences

Aug 27, 2024, 4:30 PM EDT - 1 year ago

MannKind to Present at Upcoming Conferences


MannKind Corporation (MNKD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 12:29 PM EDT - 1 year ago

MannKind Corporation (MNKD) Q2 2024 Earnings Call Transcript


MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 4:31 PM
Enter: $MNKD Calls Strike Price: $6 Expiry Date: NOV 14 2025 Buy in Price: $0.20 - $0.50 Sell Price: $0.28 Profit : +41% (Turn every $1 into $1.41) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
NatesNotes
NatesNotes Oct. 25 at 3:27 PM
SCAM ALERT - though I have already made one post about it, just a heads up to everyone on the stream that the fraudulent account that is attempting to look like mine (same screen name, but no "s" after "Nate") is now apparently also soliciting people to open and fund trading accounts "in order to follow Nate Pile's trades" (or similar); however, please note that it is a SCAM, and rather than opening an account, you should instead report the fraudulent account to ST (click on the three dots associated with that profile and then click "report"). I have sent a message to ST and one of its founders in hopes they will remove the account before anyone gets hurt, but if you could all report @NateNotes as well, it would likely help accelerate the process. Thanks in advance (and, of course, Go $MNKD! :-) ).
1 · Reply
kevinmik
kevinmik Oct. 25 at 3:17 PM
$MNKD Here are the choices facing Mannkind Board of Directors for the future direction of the company to best unlock value for shareholders. The status quo cannot continue and to meet their fiduciary responsibility Mannkind Board of Directors must start doing what's in the best interest of their sareholders. They cannot continue to allow Mannkind Executives to enrich themselves year after year approving undeserved compenstion packages and focus on shareholder value. 1) Sell Mannkind 2) Merge Mannkind With United Therapeutic 3) Restructure Mannkind Spinning Out A New Company 4) Sell Tyvaso DPI Asset To United Therapeutic To Focus Mannkind Other Assets 5) Sign New Partnership Deals 6) Have United Therapeutic or Another Pharma Company Take Equity Stake In Mannkind 7) Expand Mannkind Innovative Inhaled Drug Delivery Platform To Include Multiple Diseases & Disorders 8) Hold Management & CEO Accountable For Growing Shareholder Value, Stock Price & Market Cap 9) Hire New CEO
1 · Reply
kevinmik
kevinmik Oct. 25 at 1:59 PM
$MNKD Furoscix and Furoscx ReadyFlow Autoinjector still MIA from Mannkind website. This should have been ready to go as soon the acquisition deal closed that happened on October 7, 2025.
1 · Reply
beerm
beerm Oct. 25 at 5:21 AM
$MNKD Looks like BP is using hedge funds to increase the short position. I can smell the fears coming from BP.
1 · Reply
Kool_Aid_Mann
Kool_Aid_Mann Oct. 25 at 3:14 AM
$MNKD While all of the indices are setting record highs, MNKD is down 20% for the year, what's new? Down 66% on 10 years, down 90%+ for all time.
1 · Reply
kevinmik
kevinmik Oct. 25 at 2:50 AM
$MNKD Things kick off next Wednesday October 29th, when United Therapeutic releases their 3Q 2025 earnings report and then Mannkind is presenting Inhale-1 full study including safety extension results the next week on Wednesday November 5th and release 3Q Earnings results with host conference call the following day on Thursday November 6th. Mannkind could also release other catalyst updates over the next 2 week. Will be interesting to see where the stock price is trading 2 weeks from today on November 7th. Will it remain stuck in the $5 range or will it finally break above $6, $7 or higher.
2 · Reply
NatesNotes
NatesNotes Oct. 24 at 11:46 PM
$MNKD Love it! After getting burned so badly last time around, it will interesting to see how how much money they're willing to lose on this go 'round before they finally throw in the towel again – you'd think they would have learned their lesson by now! Either way - more fun and excitement (and profits!) for the rest of to look forward to, eh? ;-) As always, thanks for sharing, SLA! Cheers! #knowwhatyouown #factsmatter
2 · Reply
Golf365
Golf365 Oct. 24 at 11:07 PM
$MNKD In 2 weeks time we gained 7 million more short shares. Now at 25 million short. Mike, please leave and take the BOD with ya.
0 · Reply
MrSpeaker
MrSpeaker Oct. 24 at 11:03 PM
$MNKD The_Owl_ What is your take on 7,000,000 +- shares short Mnkd ? Should we be surprised ?
1 · Reply
MrSpeaker
MrSpeaker Oct. 24 at 10:55 PM
$MNKD
0 · Reply
rooksleanne
rooksleanne Oct. 24 at 10:21 PM
$MNKD Scripts Friday 
1 · Reply
YolitheDolly
YolitheDolly Oct. 24 at 10:12 PM
$MNKD As usual, this pos wipes out all the gains I made today in my other investments. Thanks Mike!
0 · Reply
Pickin
Pickin Oct. 24 at 9:06 PM
$MNKD another stellar weekly performance of mediocrity
1 · Reply
HumphreyB
HumphreyB Oct. 24 at 9:04 PM
$MNKD Market is flaming hot, this is also a flaming you know what
0 · Reply
clan
clan Oct. 24 at 9:02 PM
$MNKD Afrezza Jake, racecar driver Conor Daly, super heroin StarGirl, LEO Timothy Brown, and .... King Trump. All users of Afrezza.
1 · Reply
sla55
sla55 Oct. 24 at 8:59 PM
$MNKD Short Interest 10/15/25: 25,157,617 (SP: $5.23) Days to cover: 5.18452 Short Interest 9/30/25: 18,311,133 (SP: $5.37) Change: 6,846,484
4 · Reply
Golf365
Golf365 Oct. 24 at 8:46 PM
$MNKD This is a total slap in shareholders faces. Anyone who approves of Castagna is a flaming moron.
1 · Reply
HumphreyB
HumphreyB Oct. 24 at 8:41 PM
$MNKD Guys, be careful there's a fake @zmanx, posting as @zmanx1, @zmanx11, trying to convince people to use "tradeechocapital", which is a scam site. @MayorofMNKD I see you follow him, make sure to report and do not listen to him.
0 · Reply
firefox2778
firefox2778 Oct. 24 at 8:30 PM
$MNKD I remember talking with you about Nokia and you told me that was a chitty company (and it is). Well, today sold my LT position of more than 25k shares built around $3.10-3.15 when stock was awful. Imagine that, I was able to make money with Nokia (a miracle), probably, I’ll have a chance to make money here too. Thanks Gosh my position in Magnificent 7 is doing extraordinary (started to sell some too because run is too long to last) and probably MNKD is next? Hope so for everyone
1 · Reply
Hard2beLong
Hard2beLong Oct. 24 at 8:25 PM
$MNKD I have to admit that in one thing this stock is unique. In 14 years it has been always a roller coaster, always. Still waiting for my double digits and for embarrassment of riches
0 · Reply
santinov
santinov Oct. 24 at 8:24 PM
$MNKD The Clanster quoted/pumped Oppenheimers $15 projection for MNKD. I actually think that those might be the Clan's IQ...... Now he's moved on to Cipla and India without even realizing that the average annual Income in India is US. 2,400. ( AVG income for USA 67,000 or 28X that of India ) Average weekly scripts for USA are between 850 and 900 in America where citizens earn 28 times the income of Indians...... Cows are sacred in India but it is unlikely, considering the economics, that Afrezza will become a cash cow. The Clanster has never let reality intercede in his passionate pumping of mike. I think they both get their jollies from it. Otherwise our resident cherry picking Clanster should reflect on these real numbers MNKD 1 day... down 3.28% 5 days..down 2.93% 1 month down .38% Red for the day, week and month! It's time for $15.OO IQ pumpster Clan to push the Cipla cash cow in india where it's citizens earn 2,400 annually. Dementia reigns!
1 · Reply